The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight loss, but there are doubts over their long-term safety. New drugs such as lorcaserin and phentermine ...

After a nurse practitioner was acquitted of illegally prescribing controlled substances, she sues the United States Government and the Drug Enforcement Administration (DEA) Diversion Investigator. The ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...